Health Care
Commentary
Pending Government Drug Pricing Will Harm Seniors’ Care And Budgets
Any day now, the Biden administration will publish the prices it has set for ten drugs covered by Medicare’s Part D prescription drug benefit. These price controls will provide “meaningful financial relief for millions of people with Medicare,” administration officials say. Many seniors are about to see just how false that ...
Commentary
Harris is wrong about medical debt
Is Vice President Kamala Harris trying to rebrand as a centrist? She has recently disavowed her previous progressive positions on everything from border security to fracking to “Medicare for All.” But she and her running mate remain enthusiastic about socializing medical debt. In a recent statement, Harris claimed that “more than 100 million Americans struggle with medical ...
Commentary
The Anti-Competitive Middlemen Harming Pharmacies And Patients
Astonishing drug innovations are improving the lives of patients including those living with cancer and autoimmune disorders. These innovations also expose the payment system’s fundamental flaws. The Federal Trade Commission’s (FTC) recently released interim report on pharmacy middlemen demonstrates that these flaws impose a high cost on patients and neighborhood pharmacies. These ...
Commentary
Read the latest on pharmaceutical benefit managers
Legislation Urgently Needed to Rein In Pharmacy Benefit Mgrs.
The U.S. House Committee on Oversight and Accountability held a hearing last month with the CEOs of the nation’s three largest pharmacy benefit managers: CVS Caremark, Express Scripts, and OptumRx. The hearing coincided with a new report from the committee on the outsized role these prescription-drug middlemen play in determining what people pay for ...
Commentary
Joe Biden Leaves Behind A Disastrous Healthcare Legacy
President Joe Biden’s term will expire on January 20, 2025, when a new president will be inaugurated. He brought his decades-long political career to a close last month when he announced he would not seek re-election. Biden has thrown his support to his vice president, Kamala Harris, in this November’s election. ...
Blog
For Third Year in a Row, PRI Survey Finds Vast Majority of Americans Are Satisfied with their Health Coverage
For Third Year in a Row, PRI Survey Finds Vast Majority of Americans Are Satisfied with their Health Coverage Just 37% Support Government Health Care Takeover SACRAMENTO – For the third year in a row, an overwhelming majority of Americans say they are satisfied with their current health coverage, based ...
Commentary
Obamacare needs to police fraud
Are Obamacare’s exchanges hotbeds of fraud? New research suggests as much. An estimated 4 million to 5 million people have received fully subsidized health insurance by misrepresenting their income. That’s $20 billion lost to bogus enrollments this year. The problem stems from the original design of Obamacare – and the ...
Commentary
Vance Must Put America First on Healthcare
Ohio Sen. J.D. Vance has made quite a splash since arriving in Washington less than two years ago. He’s gone from the junior senator from Ohio and the 96th by seniority to the top of the Republican ticket as Donald Trump’s running mate. Vance has branded himself as an “America First” conservative. ...
Commentary
Kamala Harris’s healthcare record is rotten to the core
Democrats, including former President Barack Obama, have enthusiastically rallied around Vice President Kamala Harris as their presumptive presidential nominee. Voters will not be nearly as enthusiastic about her record on healthcare. Harris stands to President Joe Biden’s left on health policy. If elected, she would almost certainly drag the United States closer to a complete government ...
Commentary
Read the latest on the 340B Drug Pricing Program
Reforming 340B to Serve the Interests of Patients, Not Institutions
By Anthony M. DiGiorgio, DO, MHA and Wayne Winegarden, PhD Enacted by the US Congress in 1992 to help entities serving lower-income and uninsured patients stretch their resources, the 340B Drug Pricing Program mandated drug companies give large discounts to covered entities (CEs). Judging the program on its outcomes, not its intentions, ...
Pending Government Drug Pricing Will Harm Seniors’ Care And Budgets
Any day now, the Biden administration will publish the prices it has set for ten drugs covered by Medicare’s Part D prescription drug benefit. These price controls will provide “meaningful financial relief for millions of people with Medicare,” administration officials say. Many seniors are about to see just how false that ...
Harris is wrong about medical debt
Is Vice President Kamala Harris trying to rebrand as a centrist? She has recently disavowed her previous progressive positions on everything from border security to fracking to “Medicare for All.” But she and her running mate remain enthusiastic about socializing medical debt. In a recent statement, Harris claimed that “more than 100 million Americans struggle with medical ...
The Anti-Competitive Middlemen Harming Pharmacies And Patients
Astonishing drug innovations are improving the lives of patients including those living with cancer and autoimmune disorders. These innovations also expose the payment system’s fundamental flaws. The Federal Trade Commission’s (FTC) recently released interim report on pharmacy middlemen demonstrates that these flaws impose a high cost on patients and neighborhood pharmacies. These ...
Read the latest on pharmaceutical benefit managers
Legislation Urgently Needed to Rein In Pharmacy Benefit Mgrs.
The U.S. House Committee on Oversight and Accountability held a hearing last month with the CEOs of the nation’s three largest pharmacy benefit managers: CVS Caremark, Express Scripts, and OptumRx. The hearing coincided with a new report from the committee on the outsized role these prescription-drug middlemen play in determining what people pay for ...
Joe Biden Leaves Behind A Disastrous Healthcare Legacy
President Joe Biden’s term will expire on January 20, 2025, when a new president will be inaugurated. He brought his decades-long political career to a close last month when he announced he would not seek re-election. Biden has thrown his support to his vice president, Kamala Harris, in this November’s election. ...
For Third Year in a Row, PRI Survey Finds Vast Majority of Americans Are Satisfied with their Health Coverage
For Third Year in a Row, PRI Survey Finds Vast Majority of Americans Are Satisfied with their Health Coverage Just 37% Support Government Health Care Takeover SACRAMENTO – For the third year in a row, an overwhelming majority of Americans say they are satisfied with their current health coverage, based ...
Obamacare needs to police fraud
Are Obamacare’s exchanges hotbeds of fraud? New research suggests as much. An estimated 4 million to 5 million people have received fully subsidized health insurance by misrepresenting their income. That’s $20 billion lost to bogus enrollments this year. The problem stems from the original design of Obamacare – and the ...
Vance Must Put America First on Healthcare
Ohio Sen. J.D. Vance has made quite a splash since arriving in Washington less than two years ago. He’s gone from the junior senator from Ohio and the 96th by seniority to the top of the Republican ticket as Donald Trump’s running mate. Vance has branded himself as an “America First” conservative. ...
Kamala Harris’s healthcare record is rotten to the core
Democrats, including former President Barack Obama, have enthusiastically rallied around Vice President Kamala Harris as their presumptive presidential nominee. Voters will not be nearly as enthusiastic about her record on healthcare. Harris stands to President Joe Biden’s left on health policy. If elected, she would almost certainly drag the United States closer to a complete government ...
Read the latest on the 340B Drug Pricing Program
Reforming 340B to Serve the Interests of Patients, Not Institutions
By Anthony M. DiGiorgio, DO, MHA and Wayne Winegarden, PhD Enacted by the US Congress in 1992 to help entities serving lower-income and uninsured patients stretch their resources, the 340B Drug Pricing Program mandated drug companies give large discounts to covered entities (CEs). Judging the program on its outcomes, not its intentions, ...
